Lower CD28 expression is a marker of T-cell senescence, and increased CD8+CD28− subset populations play heterogeneous roles in cancers such as lung cancer and breast cancer [24–26], but few studies have been related to NPC. This evidence concerns the gene CD28 and nasopharyngeal carcinoma.